Groowe Groowe / Newsroom / JNJ
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

JNJ News

Johnson & Johnson

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

prnewswire.com
JNJ

The Galien Foundation Announces 2026 Prix Galien USA, International Prix Galien and Prix Galien Patient First Award Recipients

prnewswire.com
DNLI GH PT CRC REGN SNY VRTX IMCR BMY LAB JNJ AZN

Veterinary Implants Devices Market worth $0.98 billion by 2031 - Exclusive Report by MarketsandMarkets™

prnewswire.com
MRK ELAN JNJ ZTS HBIO

LUNGevity Foundation Unites Communities to Advance Progress During 2026 Lung Cancer Awareness Month

prnewswire.com
AZN JNJ AMGN LLY MRK REGN

Melissa Etheridge to Accept 2026 Hope Award for Mental Health Advocacy at 20th Annual HOPE Luncheon Seminar

prnewswire.com
JNJ

LUNGevity Foundation Launches Every Breath Forward℠ to Advance Progress and Improve Lives Nationwide

prnewswire.com
BIIB AZN JNJ AMGN LLY MRK REGN

Industry Report Shows 64% of Life Sciences Leaders Taking Action to Establish AI Governance

prnewswire.com
MRNA PFE JNJ